Clinical trials on drug repositioning for COVID-19 treatment
Brief Communication
[키워드] 2019-nCoV
approved
bevacizumab
China
Chloroquine
clinical
clinical trial
clinical trials
Clinical trials as topic
coronavirus
Coronavirus infection
Coronavirus pneumonia
COVID-19
database
death
disease
distribution
drug repositioning
eligibility criteria
ensaios clínicos como assunto
ensayos clínicos como asunto
facilitate
Favipiravir
genus Betacoronavirus
human immunoglobulin
humans
Hydroxychloroquine
Infecções por Coronavirus
infecciones por coronavirus
interferons
Intervention
less
limitations
mammals
Medicine
Medicines
Methylprednisolone
neumonía viral
novel coronavirus disease
novel coronavirus SARS-CoV-2
oseltamivir
outbreak
Pandemias
Pandemics
participant
Patient
performed
Pneumonia viral
Pneumonia, viral
Remdesivir
reported
Reposicionamento de medicamentos
Reposicionamiento de medicamentos
retrieved
Ritonavir
RNA virus
TCM
Traditional Chinese medicine
Treatment
Trial
viroses
virosis
Virus diseases
WHO
World Health Organization
Wuhan
[DOI] 10.26633/RPSP.2020.40 PMC 바로가기 [Article Type] Brief Communication
[DOI] 10.26633/RPSP.2020.40 PMC 바로가기 [Article Type] Brief Communication